1/70
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Dysthymic Disorder
Depressed mood for at least 2 years, never without symptoms for more than 2 months during 2 year period. No major depressive episode. Lifetime prevalence: 3%
Depression epidemiology
~16-17%, leading cause of disability (10%) more prevalent in recent generations
Depression course
Onset: adolescence and young adulthood. Earlier onset = more severe
Gender and Depression
2x more common in women—> more likely to present at health clinics
Depression Environmental Factors
Stressful life events, lack of social support
Depression Biological Factors
HPA axis, genetics, brain function, neurochemicals
Depression Psychological Factors
Information processing bias, cognitive distortions, rumination, personality
HPA Axis
Central regulator of stress response, improper regulation of cortisol could lead to depression
Brain Regions where decreased functioning/volume relates to depression
OFC = reward
DLPFC = cognitive control
ACC = selective attention
Hippocampus = learning and memory
Barin region where increased function relates to depression
Amygdala = emotion and threat
Beck’s Negative Cognitive Triad
Critical incident leads to core belief formed in early experience to be activated which leads to negative thoughts about self, future, and world
Negative Attribution Style
Internal, global, stable
Negative Schemata
tend to view world negatively, process information in negative ways as a result
Unipolar Disorders Treatments
Cognitive Therapy, Interpersonal therapy, Behavioral activation treatment
Cognitive Therapy
Replacing self defeating thoughts with rational statements
Interpersonal Therapy
Focuses on current relationships and improving them via communication
Behavioral Activation Treatment
Plan positive activities and force self to go
Antidepressant Medications
SSRI, SNRI, MAO, TCA
SSRI
Selective serotonin reuptake inhibitors, preferred
50% or larger reduction of symptoms
Prozac, Paxil
Problems: nausea, insomnia
SNRI
Serotonin and norepinephrine reuptake inhibitors
MAO
Monoamine Oxidase Inhibitors - inhibit enzymes that break down serotonin and norepinephrine
TCA
Tricyclic Antidepressants - inhibit norepinephrine reuptake(and serotonin in small amounts)
TMS(transcranial magnetic stimulation)
Stimulates brain regions to increase or decrease activity. Increasing left PFC activity is beneficial for depression
Suicide Epidemiology
Highest rate in white men over 50, increased among adolescents. Males more lethal
Durkheim’s Classification
Egotistic: alienated and lost
Altruistic: sacrifice for society
Anomic: breakdown for social order
Fatalistic: unbearable life circumstances
Suicide Psychosocial factors
Impulsivity, Aggression, Pessimism, Family psychopathology, genetics, sociocultural factors
David Klonsky’s framework
Starts with ideation then progresses to attempts. Most people with ideation don’t attempt.
Thomas Joiner’s Approach to Suicide
Being a burden, social isolation, acquired ability to inflict lethal self injury
Bipolar I
At least one manic episode
Bipolar II
At least one major depressive episode
At least one hypomanic episode
No manic episodes
Cyclothymia
No manic of MD episodes but rapid fluctuations in mood
Manic episode
A period of elevated, expansive, or irritable mood
last about a week
Grandiosity/inflated self esteem, talkative, distractible, goal oriented activity
Causes significant distress of impairment
Bipolar Epidemiology
Occurs equally in males and females, starts in adolescence or young adulthood, average age of onset 22 years, 3x as many depressed days as manic/hypomanic
Bipolar Environmental Factors
Stressful life events, goal attainment, schedule disruption, lack of sleep
Bipolar biological factors
Genetic vulnerability, brain fucntion
Bipolar psychological factors
Cognitive distortions, grandiose thinking
Bipolar and Brain function
Hypoactivation of reward circuit to small gains
Treatment for Bipolar Disorders
Lithium = effective for mania, 40% don’t improve, side effects cause noncompliance
Anticonvulsants = Tegretol, Depakene, ~50% respond, used for rapid cycling, gastrointestinal side effects
Psychotherapy and Bipolar Disorders
Can supplement biological intervention but is not effective alone. Cognitive Therapy combined works better than meds alone
Anxiety Social Factors
Stressful life events involving danger, insecurity, family discrod
Childhood adversity
Exposed to more anxiety in parents
Anxiety Biological Factors
Genetics, behavioral inhibition temperament, stronger amygdala response
Insula
Connected to autonomic nervous system, critical for interception, bodily perception, increased activity in anxiety
Specific Phobia
Marked and persistent fear that is excessive or unreasonable cued by presence or anticipation of a specific object or situation. Avoidance, interfered with daily life
Specific Phobia Epidemiology
Lifetime prevalece ~12%, more common in women
Etiology of Specific Phobias
Evolutionary adaptation, classical conditioning
Preparedness Theory of Phobias
Biologically prepared for associations, learned in one trial and are difficult to extinguish, easy to condition fear to snakes or spiders and more difficult for neutral objects
Fear-Avoiaence Hierarchy
Start with thinking about stimulus and end with interacting with it closely
Social Anxiety Disorder
Marked and persistent fear of one or more social or performance situations. Situations are avoided or endured with great distress and they interfere with functioning
Specific SAD
one to three feared situations
Generalized SAD
4 or more feared situations
SAD Prevalence
~12.1% lifetime prevalence, higher rates in women, age of onset childhood to mid-adolescence.
SAD Environmental Risks
Bullying in childhood, childhood neglect/abuse, maternal overprotection
Cognitive Behavioral Theory of SAD
Beliefs: negative evaluation is likely, being liked is important
Hyper-vigilance: heightened attention to signs of social threat(eye tracking)
SAD Treatment
SSRIs and sometimes benzodiazepines
Group or individual CBT, attention Bias retraining
Panic Disorder
Recurrent and unexpected panic attacks, persistent concern about having an additional panic attack
Agoraphobia
Anxiety in situations from which escape might be difficult. Mostly female
Panic Disorder Prevalence
3.5% lifetime prevalence, twice as common in females, Chronic, age of onset 23-34
Catastrophic Misinterpretation
Panic attacks triggered by internal stimuli, anxious mood leads to physiological sensations, narrowed attention and increased awareness of bodily sensations, person misinterprets bodily sensations as catastrophic event(fear of fear)
Panic disorder Treatment
Interoceptive exposure = deliberate exposure to feared internal situations
Cognitive therapy = target catastrophic automatic thoughts
Psychoeducation
GAD Prevalence
Lifetime: 5.7%
Age of onset 31 or 33
High comorbidity with MDD
Tri-partite model of mood and anxiety disorders
Negative Affect (shared by mood and anxiety disorders)
Positive affect (MDD)
Physiological hyper-arousal (anxiety)
GAD specific symptoms
Worry, cognitive biases, intolerance of uncertainty, GABA/benzodiazepine receptor dysfunction
GAD Treatements
SSRIs, benzodiazepines
CBT
Treatments that target avoidance of emotion = Interpersonal and emotional processing therapy, mindfulness-based CBT for GAD, emotion regulation therapy
CBT for GAD
Self monitoring, antecedent cognitive reappraisal, prevention of emotional avoidance = emotional awareness training
Obsessions
Recurrent and persistent thoughts, impulses, causes anxiety, person attempts to suppress and recognizes thoughts are from their own mind
Compulsions
Repetitive behaviors or mental acts that person feels driven to preform in response to obsession
ODC Epidemiology
Lifetime prevalence 2.3%, affects both genders equally, begins in adolescence or early adulthood, comorbid with mood and anxiety disorders and body dysmorphic disorder
OCD Psychological Factors
Avoidance learning: neutral stimuli associated with frightening thoughts through classical conditioning.
Once associated, anxiety is reduced with compulsive behavior
Thought suppression
OCD Genetics
moderate heritability
OCD Treatment
Exposure and prevention
SSRIs